Search filters

List of works by Alicia Okines

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

scientific article published on 12 May 2009

Accomplishments in 2008 in the management of localized gastric cancer

scientific article published on September 2009

An evaluation of FIGO 2000: the first 5 years.

scientific article published in August 2008

Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis

scientific article published on 01 March 2022

Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report

scientific article published on 28 October 2012

Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials

scientific article

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

scientific article published on 4 March 2010

Capecitabine in advanced gastric cancer

scientific article published on November 2007

Capecitabine in gastric cancer

scientific article published in 2008

Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible

scientific article published on 20 June 2011

Current and Future Therapies for Advanced Gastric Cancer.

scientific article

Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?

scientific article

De-escalating and escalating systemic therapy of early breast cancer

scientific article published on 08 July 2017

Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer

scientific article published on 07 July 2020

Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.

scientific article

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.

scientific article published on 25 January 2011

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

scientific article published on 16 November 2020

Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial

scientific article published on 11 December 2012

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial ⬇️

scientific article

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial

scientific article published on 2 August 2010

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article

Genomic loss of heterozygosity and survival in the REAL3 trial

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance

scientific article published on 07 October 2019

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

scientific article published on 29 May 2020

Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review

scientific article

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

scientific article

Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour

scientific article published on July 2010

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.

scientific article

Multimodality treatment for localized gastro-oesophageal cancer

scientific article published on October 2010

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial ⬇️

scientific article published on 04 August 2017

Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer

scientific article published on March 2011

Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

scientific article published on 18 September 2019

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial. ⬇️

scientific article published on 02 February 2017

Perioperative management of esophageal cancer

scientific article published on 09 March 2010

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

scientific article published on 2 October 2017

Progress in the multidisciplinary treatment of gastrointestinal cancers, impact on clinical practice: peri-operative management of gastro-esophageal cancer

scientific article published in September 2008

Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

scientific article published on 8 December 2010

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer

scientific article

Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience

scientific article published on 27 June 2020

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial

scientific article published on October 2009

Targeting angiogenesis in esophagogastric adenocarcinoma

scientific article published on 31 May 2011

Targeting the human EGFR family in esophagogastric cancer

scientific article published on 05 April 2011

Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues

scientific article published on 4 March 2015

To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity

scientific article published on 17 September 2018

Trastuzumab in gastric cancer

scientific article published on 11 June 2010

Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer

scientific article

Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.

scientific article

Triplet therapy with palbociclib, taselisib and fulvestrant in PIK3CA mutant breast cancer and doublet palbociclib and taselisib in pathway mutant solid cancers

scientific article published on 21 September 2020

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

scientific article published on 11 December 2019

Paulina is supported by:

About Paulina

Help